These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 162968)

  • 41. The effects of reserpine on behavior and on brain concentrations of serotonin and norepinephrine in control rats and rats with hypothalamic lesions.
    Grabarits F; Harvey JA
    J Pharmacol Exp Ther; 1966 Sep; 153(3):401-11. PubMed ID: 5921526
    [No Abstract]   [Full Text] [Related]  

  • 42. The action of black widow spider venom on cholinergic mechanisms in synaptosomes.
    Baba A; Cooper JR
    J Neurochem; 1980 Jun; 34(6):1369-79. PubMed ID: 7381466
    [No Abstract]   [Full Text] [Related]  

  • 43. Inhibition of the uptake of tritiated catecholamines by antidepressant and related agents.
    Ross SB; Renyi AL
    Eur J Pharmacol; 1967 Dec; 2(3):181-6. PubMed ID: 5591516
    [No Abstract]   [Full Text] [Related]  

  • 44. Modulation of central noradrenergic function by RS-15385-197.
    Redfern WS; MacKinnon AC; Brown CM; Martin AB; Kilpatrick AT; Clague RU; Spedding M
    Br J Pharmacol; 1993 Feb; 108(2):526-33. PubMed ID: 8095421
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Uptake of (-) 3H-norepinephrine by storage vesicles prepared from whole rat brain: properties of the uptake system and its inhibition by drugs.
    Seidler FJ; Kirksey DF; Lau C; Whitmore WL; Slotkin TA
    Life Sci; 1977 Oct; 21(8):1075-85. PubMed ID: 21338
    [No Abstract]   [Full Text] [Related]  

  • 46. Levomilnacipran (F2695), a norepinephrine-preferring SNRI: profile in vitro and in models of depression and anxiety.
    Auclair AL; Martel JC; Assié MB; Bardin L; Heusler P; Cussac D; Marien M; Newman-Tancredi A; O'Connor JA; Depoortère R
    Neuropharmacology; 2013 Jul; 70():338-47. PubMed ID: 23499664
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Irreversible binding and recovery of the norepinephrine uptake system using an alkylating derivative of norepinephrine.
    Baker SP; Standifer KM; Kalberg CJ; Pitha J; Sumners C
    J Neurochem; 1988 Apr; 50(4):1044-52. PubMed ID: 2894406
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Competition by monophenolic estrogens and catecholestrogens for high-affinity uptake of [3H](-)-norepinephrine into synaptosomes from rat cerebral cortex and hypothalamus.
    Ghraf R; Michel M; Hiemke C; Knuppen R
    Brain Res; 1983 Oct; 277(1):163-8. PubMed ID: 6315138
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential sensitivity of hypothalamic norepinephrine and striatal dopamine to catecholamine-depleting agents.
    Takimoto GS; Stittsworth JD; Bianchi BR; Stephens JK
    J Pharmacol Exp Ther; 1983 Aug; 226(2):432-9. PubMed ID: 6875857
    [No Abstract]   [Full Text] [Related]  

  • 50. Steric requirements for catecholamine uptake by rat brain synaptosomes: studies with rigid analogs of amphetamine.
    Horn AS; Snyder SH
    J Pharmacol Exp Ther; 1972 Mar; 180(3):523-30. PubMed ID: 5012779
    [No Abstract]   [Full Text] [Related]  

  • 51. Correlations between phospholipid methylation and neuronal catecholamine transport.
    Samet MK; Rutledge CO
    Biochem Pharmacol; 1984 Nov; 33(22):3547-51. PubMed ID: 6508817
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regional differences in the high affinity uptake or 3H-dopamine and 3H-norepinephrine in synaptosome rich homogenates of cat brain.
    Garey RE
    Life Sci; 1976 Feb; 18(4):411-8. PubMed ID: 1256245
    [No Abstract]   [Full Text] [Related]  

  • 53. 3H-normetanephrine uptake in rat brain slices. Relationship to extraneuronal accumulation of norepinephrine.
    Hendley ED; Taylor KM; Snyder SH
    Eur J Pharmacol; 1970 Oct; 12(2):167-79. PubMed ID: 4394372
    [No Abstract]   [Full Text] [Related]  

  • 54. Release of biogenic amines from isolated nerve endings.
    Raiteri M; Bertollini A; del Carmine R; Levi G
    Adv Exp Med Biol; 1976; 69():319-35. PubMed ID: 941741
    [No Abstract]   [Full Text] [Related]  

  • 55. On the pharmacology of syrosingopine and reserpine.
    Pham-Huu-Chanh ; De Schaepdryver AF
    Arch Int Pharmacodyn Ther; 1965 Sep; 157(1):207-13. PubMed ID: 4380062
    [No Abstract]   [Full Text] [Related]  

  • 56. Lability in storage of 3H-dopamine and 3H-norepinephrine in crude synaptosome (P2) and vesicle-associated fractions of rat brain.
    Bianchi BR; Takimoto GS
    Life Sci; 1984 Feb; 34(7):607-15. PubMed ID: 6700371
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes.
    Bolden-Watson C; Richelson E
    Life Sci; 1993; 52(12):1023-9. PubMed ID: 8445992
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Release of somatostatin from rat brain synaptosomes.
    Bennett GW; Edwardson JA; Marcano de Cotte M; Berelowitz M; Pimstone BL; Kronheim S
    J Neurochem; 1979 Mar; 32(3):1127-30. PubMed ID: 430048
    [No Abstract]   [Full Text] [Related]  

  • 59. Active uptake of tritiated metaraminol by mouse brain slices in vitro.
    Ross SB; Renyi AL
    Life Sci; 1966 Apr; 5(7):639-47. PubMed ID: 4381260
    [No Abstract]   [Full Text] [Related]  

  • 60. [Synaptosomal transport of cerebral tryptophan and tyrosine. Stimulation of the rate of uptake after administration of reserpine or monoamine oxidases inhibitor].
    Belin MF; Chouvet G; Pujol JF
    Biochem Pharmacol; 1974 Feb; 23(3):587-97. PubMed ID: 4822744
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.